hydroxychloroquine has been researched along with Devic Disease in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, L | 1 |
| Wang, Z | 1 |
| Song, HH | 1 |
| Zhou, YF | 1 |
| Chen, C | 1 |
| Yan, YP | 1 |
| Qiu, W | 1 |
| Foroughipour, M | 1 |
| Nikbin, Z | 1 |
| Sahebari, M | 1 |
| Pezeshki Rad, M | 1 |
| Shoeibi, A | 1 |
2 other studies available for hydroxychloroquine and Devic Disease
| Article | Year |
|---|---|
Hydroxychloroquine fails to attenuate lesion development in a mouse model of neuromyelitis optica.
Topics: Animals; Brain; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Enzyme Inhibitors; Female | 2018 |
Devic syndrome: can antiphospholipid antibodies be a factor?
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agen | 2012 |